Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to $71.8 million.

  • Abivax's Shares Outstanding (Diluted Average) rose 5.98% to $71.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $71.8 million, marking a year-over-year increase of 5.98%. This contributed to the annual value of $67.4 million for FY2024, which is 45.40% up from last year.
  • Abivax's Shares Outstanding (Diluted Average) amounted to $71.8 million in Q2 2025, which was up 7.72% from $66.7 million recorded in Q1 2025.
  • In the past 5 years, Abivax's Shares Outstanding (Diluted Average) ranged from a high of $71.8 million in Q2 2025 and a low of $17.7 million during Q4 2021.
  • Over the past 3 years, Abivax's median Shares Outstanding (Diluted Average) value was $67.6 million (recorded in 2024), while the average stood at $64.7 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 137.88% in 2023, then declined by 2.46% in 2025.
  • Quarterly analysis of 5 years shows Abivax's Shares Outstanding (Diluted Average) stood at $17.7 million in 2021, then increased by 10.17% to $19.5 million in 2022, then spiked by 137.88% to $46.3 million in 2023, then soared by 45.40% to $67.4 million in 2024, then increased by 5.98% to $71.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $71.8 million in Q2 2025, compared to $66.7 million in Q1 2025 and $67.4 million in Q4 2024.